Tebufenpyrad/metaflumizone suspension agent and production method thereof
A technology of fenflufen and fenflufen, which is applied in the field of suspending agents of fenflufen and fenflufen, can solve the problems such as no literature on the compounding and application of fenflufen and fenflufen, and the like. The effect of overcoming and pest resistance, reducing pollution and prolonging control time
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0021] The suspension concentrate of tebufenfen and metaflumizone of the present embodiment is made up of the following components by weight percentage:
[0022] Tebufenfen 10%
[0023] Metaflumizone 10%
[0024] Surfactant 6%
[0025] water balance
[0026] In this embodiment, the weight content of the active ingredients tebufenfen and metaflumizone is 20%. Dispersants and wetting agents are used as surfactants. Sodium lignosulfonate and methyl naphthalene sulfonate formaldehyde condensate sulfate are selected as the dispersant, with a weight content of 3% and 2% respectively; nonylphenol polyoxyethylene ether is used as a wetting agent, with a weight content of 1%.
[0027] The production method of the suspending agent of tebufenpyrad and metaflumizone in this embodiment is that the active ingredients tebufenpyrad and metaflumizone are added to water, and then a surfactant is added, mixed, and wet through a vertical sand mill. Pulverize, and finally mix evenly to get th...
Embodiment 2
[0029] The difference between this example and Example 1 is that the suspension concentrate of tebufenfen and metaflumizone in this example is composed of the following components in weight percentage:
[0030] Tebufenfen 10%
[0031] Metaflumizone 20%
[0032] Surfactant 4.5%
[0033] water balance
[0034] The weight content of the active ingredients tebufenfen and metaflumizone in this example is 30%. Dispersants and wetting agents are used as surfactants. The dispersant is polycarboxylate with a weight content of 4%; the wetting agent is sodium lauryl sulfate with a weight content of 0.5%.
Embodiment 3
[0036] The difference between this example and Example 1 is that the suspension concentrate of tebufenfen and metaflumizone in this example is composed of the following components in weight percentage:
[0037] Tebufenfen 15%
[0038] Metaflumizone 25%
[0039] Surfactant 6%
[0040] water balance
[0041] In this embodiment, the weight content of the active ingredients tebufenfen and metaflumizone is 40%. Dispersants and wetting agents are used as surfactants. The dispersant is sodium N-methyl fatty acyl taurate, with a weight content of 5%; the wetting agent is pull-off powder, with a weight content of 1%.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com